Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eagle Pharmaceuticals Inc (EGRX)
NASDAQ:EGRX
RESEARCH TOOLSreports
Eagle Pharmaceuticals (EGRX) Financial Statements
185 Followers
Eagle Pharmaceuticals Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 64.65M | $ 46.22M | $ 60.70M | $ 65.90M | $ 74.14M |
| Gross Profit | $ 47.79M | $ 83.61M | $ 42.46M | $ 42.25M | $ 50.47M |
| EBIT | $ 10.75M | $ 11.75M | $ 14.97M | $ -2.07M | $ -5.32M |
| EBITDA | $ 17.42M | $ 17.80M | $ 21.05M | $ 1.78M | $ -3.68M |
| Net Income Common Stockholders | $ 5.16M | $ 114.81M | $ 8.16M | $ -7.13M | $ -9.45M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 15.35M | $ 21.90M | $ 55.32M | $ 15.38M | $ 36.56M |
| Total Assets | $ 404.82M | $ 414.18M | $ 406.16M | $ 386.45M | $ 381.76M |
| Total Debt | $ 70.19M | $ 76.33M | $ 62.47M | $ 64.77M | $ 53.59M |
| Net Debt | $ 54.84M | $ 54.43M | $ 7.14M | $ 49.39M | $ 17.03M |
| Total Liabilities | $ 152.78M | $ 171.33M | $ 172.60M | $ 154.67M | $ 143.77M |
| Stockholders Equity | $ 252.04M | $ 242.84M | $ 233.56M | $ 231.78M | $ 237.98M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -132.00K | $ -33.52M | $ 37.55M | $ -13.24M | $ 42.99M |
| Operating Cash Flow | $ -126.00K | $ -33.46M | $ 37.56M | $ -13.24M | $ 42.99M |
| Investing Cash Flow | $ -6.00K | $ -12.56M | $ -9.00K | $ -11.24M | $ -75.42M |
| Financing Cash Flow | $ -6.41M | $ 12.65M | $ 2.39M | $ 3.30M | $ -536.00K |
Eagle Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.